Business Parks & Science Centres

 
 
 

Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px
Organisation › Details

Secarna (Group)

Secarna Pharmaceuticals is the next generation antisense oligonucleotide (ASO) company with multiple innovative antisense therapies in various stages of pre-clinical development in the areas of immunooncology, ophthalmology, immunology, fibrotic diseases (airways, liver, kidney), and anti-viral applications. Secarna's mission is to maximize the performance and output of its proprietary LNAplusTM antisense oligonucleotide discovery platform, to develop highly specific, safe, and efficacious antisense therapies for challenging or currently not druggable targets. *

 

Period Start 2015-01-28 established
Persons Person Bille, Joachim (Secarna + Genova + Sterna Biologicals 201604 Managing Director)
  Person 2 Renz, Jonas (Secarna + Genova + Sterna Biologicals 201604 Managing Director)
     
Region Region Marburg
  Country Germany
  Street 19 Am Klopferspitz
  City 82152 Martinsried
  Tel +49-89-215-46-375
    Address record changed: 2018-06-05
     
Basic data Employees n. a.
     
    * Document for �About Section�: Secarna Pharmaceuticals GmbH & Co. KG. (6/4/18). "Press Release: Secarna Pharmaceuticals Introduces LNAplus, Its Proprietary, Customized, Third Generation Antisense Oligonucleotide (ASO) Drug Discovery and Development Platform". Martinsried.
     
   
Record changed: 2018-06-05

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

More documents for Secarna (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px




» top